We thank one anonymous reviewer for Selleckchem GSK-3 inhibitor their helpful suggestions. We are also grateful to various organisations for funding. This report is independent research arising from

ECG’s Ph.D. studentship attached to a Natural Environment Research Council grant [grant number NE/G007349/1]. OLP was part funded by the Royal Society and University of Zürich. ABP has a Wellcome Trust Centre for Immunity, Infection and Evolution Advanced Fellowship. None of the funding organisations played any role in the planning, implementation or documentation of this research. “
“The affiliation in the article YAP Expression in Normal and Neoplastic Breast Tissue: An Immunohistochemical Study, which appeared in Volume 45, Number 3, page 223, listed as the first affiliation should read as Sirolimus follows: aHospital General de Zona No. 16, Instituto Mexicano del Seguro Social (IMSS), Torreon, Coahuila, Mexico We apologize for any confusion or inconvenience this may have caused. “
“The title of the article Combined Assessment of Endothelial Growth Factor Receptor Dual Color In Situ Hybridization and Immunohistochemistry with Downstream Gene Mutations in Prediction of Response to the Anti-EGFR Therapy for Patients with Metastatic Colorectal Cancer, which appeared in Volume 45, Number 5, page 366, should read as follows: Combined Assessment of Epidermal Growth Factor Receptor Dual Color In Situ Hybridization and Immunohistochemistry with

Downstream Gene Mutations in Prediction of Response to the Anti-EGFR Therapy for Patients with Metastatic Colorectal Cancer We apologize for any confusion or inconvenience this may have caused. “
“The acknowledgment in the article Anti-influenza Viral Effects of Honey In Vitro: Potent High Activity of Manuka Honey, which appeared in Volume Tacrolimus (FK506) 45, Number 5, page 359, should read as follows: Acknowledgments This work was partly supported by a grant from Yamada Bee Farm for Honeybee

Research (0107 and 0131) and a grant from the gCOE program of Nagasaki University. We apologize for any confusion or inconvenience this may have caused. “
“Epidermolysis bullosa (EB) is an inherited disease characterized by an extremely fragile skin and mucous (1). EB patients develop blisters and sores on the skin, spontaneously or because of minimum friction. The disease has a genetic background and, according to its inheritance pattern, is classified in autosomal dominant EB (D-EB) or autosomal recessive EB (R-EB) 2 and 3. EB displays diversity in the clinical phenotype, which reflects variation in the genes affected (4). Three mayor subtypes have been described: EB simplex, junctional EB, and dystrophic EB (DEB) 1, 5 and 6. In EB simplex, the genes encoding keratin 5 and 14 are affected, (2) whereas in junctional EB the genes laminin alpha 3 and laminin 5 have alterations (2). DEB is caused by mutations in the type VII collagen gene (COL7A1).